The Impact of COVID-19 is included in Companion Animal Vaccine Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Companion Animal Vaccine Trends and Forecast
The future of the global companion animal vaccine market looks promising with opportunities in the hospital & clinic and research institute markets. The global companion animal vaccine market is expected to reach an estimated $4.8 billion by 2030 with a CAGR of 6.3% from 2024 to 2030. The major drivers for this market are rising awareness about importance of pet vaccination, growing cases of zoonotic diseases, and increasing interest for pet ownership in the world.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Companion Animal Vaccine by Segment
The study includes a forecast for the global companion animal vaccine by product type, species type, end use, and region.
Companion Animal Vaccine Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:
• Attenuated Live
• Conjugate
• Inactivated
• Subunit
• Toxoid
• DNA
• Recombinant
Companion Animal Vaccine Market by Species Type [Shipment Analysis by Value from 2018 to 2030]:
• Canine
• Avian
• Feline
• Equine
Companion Animal Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals & Clinics
• Research Institutes
• Others
Companion Animal Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Companion Animal Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies companion animal vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the companion animal vaccine companies profiled in this report include-
• Elanco
• Boehringer Ingelheim International
• Intervet
• Zoetis Services
• Bioveta
• Sanofi
• Bayer
• Heska
• Virbac
• Hester Biosciences
Companion Animal Vaccine Market Insights
Lucintel forecasts that canine will remain the largest segment due to increasing awareness of the importance of this vaccination among dog owners for protecting their pets from serious diseases.
Within this market, hospital & clinic is expected to witness highest growth over the forecast period.
North America will remain the largest region due to high pet ownership rates and increasing awareness of the importance of pet vaccination among population in the region.
Features of the Global Companion Animal Vaccine Market
Market Size Estimates: Companion animal vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Companion animal vaccine market size by product type, species type, end use, and region in terms of value ($B).
Regional Analysis: Companion animal vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product types, species types, end uses, and regions for the companion animal vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the companion animal vaccine market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the companion animal vaccine market size?
Answer: The global companion animal vaccine market is expected to reach an estimated $4.8 billion by 2030.
Q.2 What is the growth forecast for companion animal vaccine market?
Answer: The global companion animal vaccine market is expected to grow with a CAGR of 6.3% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the companion animal vaccine market?
Answer: The major drivers for this market are rising awareness about importance of pet vaccination, growing cases of zoonotic diseases, and increasing interest for pet ownership in the world.
Q4. What are the major segments for companion animal vaccine market?
Answer: The future of the companion animal vaccine market looks promising with opportunities in the hospital & clinic and research institute markets.
Q5. Who are the key companion animal vaccine market companies?
Answer: Some of the key companion animal vaccine companies are as follows:
• Elanco
• Boehringer Ingelheim International
• Intervet
• Zoetis Services
• Bioveta
• Sanofi
• Bayer
• Heska
• Virbac
• Hester Biosciences
Q6. Which companion animal vaccine market segment will be the largest in future?
Answer: Lucintel forecasts that canine will remain the largest segment due to increasing awareness of the importance of this vaccination among dog owners for protecting their pets from serious diseases.
Q7. In companion animal vaccine market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to high pet ownership rates and increasing awareness of the importance of pet vaccination among population in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the companion animal vaccine market by product type (attenuated live, conjugate, inactivated, subunit, toxoid, DNA, and recombinant), species type (canine, avian, feline, and equine), end use (hospitals & clinics, research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to companionanimal vaccine market or related to companion animal vaccine companies, companion animal vaccine market size, companion animal vaccine market share, companion animal vaccine market growth, companion animal vaccine market research, write Lucintel analyst at email: helpdesk@lucintel.com we will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Companion Animal Vaccine Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Companion Animal Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Companion Animal Vaccine Market by Product Type
3.3.1: Attenuated Live
3.3.2: Conjugate
3.3.3: Inactivated
3.3.4: Subunit
3.3.5: Toxoid
3.3.6: DNA
3.3.7: Recombinant
3.4: Global Companion Animal Vaccine Market by Species Type
3.4.1: Canine
3.4.2: Avian
3.4.3: Feline
3.4.4: Equine
3.5: Global Companion Animal Vaccine Market by End Use
3.5.1: Hospitals & Clinics
3.5.2: Research Institutes
3.5.3: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Companion Animal Vaccine Market by Region
4.2: North American Companion Animal Vaccine Market
4.2.1: North American Companion Animal Vaccine Market by Species Type: Canine, Avian, Feline, and Equine
4.2.2: North American Companion Animal Vaccine Market by End Use: Hospitals & Clinics, Research Institutes, and Others
4.3: European Companion Animal Vaccine Market
4.3.1: European Companion Animal Vaccine Market by Species Type: Canine, Avian, Feline, and Equine
4.3.2: European Companion Animal Vaccine Market by End Use: Hospitals & Clinics, Research Institutes, and Others
4.4: APAC Companion Animal Vaccine Market
4.4.1: APAC Companion Animal Vaccine Market by Species Type: Canine, Avian, Feline, and Equine
4.4.2: APAC Companion Animal Vaccine Market by End Use: Hospitals & Clinics, Research Institutes, and Others
4.5: ROW Companion Animal Vaccine Market
4.5.1: ROW Companion Animal Vaccine Market by Species Type: Canine, Avian, Feline, and Equine
4.5.2: ROW Companion Animal Vaccine Market by End Use: Hospitals & Clinics, Research Institutes, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Companion Animal Vaccine Market by Product Type
6.1.2: Growth Opportunities for the Global Companion Animal Vaccine Market by Species Type
6.1.3: Growth Opportunities for the Global Companion Animal Vaccine Market by End Use
6.1.4: Growth Opportunities for the Global Companion Animal Vaccine Market by Region
6.2: Emerging Trends in the Global Companion Animal Vaccine Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Companion Animal Vaccine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Companion Animal Vaccine Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Elanco
7.2: Boehringer Ingelheim International
7.3: Intervet
7.4: Zoetis Services
7.5: Bioveta
7.6: Sanofi
7.7: Bayer
7.8: Heska
7.9: Virbac
7.10: Hester Biosciences
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Companion Animal Vaccine Market Report.